The OAAA is a national coalition of concerned organizations mobilized by the Arthritis Foundation and the Centers for Disease Control and Prevention (CDC). This coalition is committed to elevating osteoarthritis (OA) as a national health priority and promoting effective policy solutions that aim to address the individual and national toll of OA.
“Under the leadership of Drs. Joanne Jordan and Leigh F. Callahan at UNC, the Thurston Arthritis Research Center is uniquely positioned to take on the OAAA,” said Melanie Thompson, Osteoarthritis Action Alliance manager at the Arthritis Foundation.
This coalition is committed to elevating osteoarthritis (OA) as a national health priority and promoting effective policy solutions that aim to address the individual and national toll of OA.
“They currently have a National Institute of Arthritis and Musculoskeletal and Skin Diseases-funded Multipurpose Clinical Research Center (MCRC) titled ‘Mitigating the Public Health Impact of Osteoarthritis,’ and the OAAA goals are completely congruent with the goals of the MCRC.
“The MCRC draws together multiple units and investigators at UNC interested in OA into novel collaborative relationships. Dr. Callahan was also part of the Steering Committee for the National Public Health Agenda for Osteoarthritis and has been involved in the OAAA since the beginning. The Arthritis Foundation remains committed to the OAAA and will provide UNC financial support to lead the OAAA through a cooperative agreement with the CDC,” Thompson said.
Leigh F. Callahan, PhD, the Mary Link Briggs Distinguished Professor of Medicine at the UNC Thurston Arthritis Research Center, will serve as Director of the OAAA.
“We are thrilled to be selected to bring this consortium to UNC and the Thurston Arthritis Research Center,” said Joanne M. Jordan, MD, MPH, the Joseph P. Archie, Jr. Eminent Professor of Medicine, Chief of the Division of Rheumatology, Allergy and Immunology and Director of the Thurston Arthritis Research Center.
“Dr. Callahan is the perfect leader for this initiative, which will dovetail beautifully with other efforts we have undertaken to improve the care of people with osteoarthritis or at high risk for osteoarthritis.”